Kiyoshi Hibi

Kiyoshi Hibi

Auto-generated profile, based on publicly available information

Kiyoshi Hibi

Yokohama City University Medical Center

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in Circulation
Verified
Journal Article
Closed access
MNMasahiro Natsuaki
Masahiro Natsuaki
HWHirotoshi Watanabe
Hirotoshi Watanabe
TMTakeshi Morimoto
Takeshi Morimoto
KYKo Yamamoto
Ko Yamamoto
YOYuki Obayashi
Yuki Obayashi
TKTakeshi Kimura
Takeshi Kimura
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in patients with acute coronary syndrome or high bleeding risk. Aspirin-free strategy might result in lower bleeding early after PCI without increasing cardiovascular events, but its efficacy and safety have not yet been proven in randomized trials. METHODS: We randomly assigned 6002 patients with acute coronary syndrome or high bleeding risk just before PCI either to prasugrel (3.75 mg/day) monotherapy or to DAPT with aspirin (81–100 mg/day) and prasugrel (3.75 mg/day) after loading of 20 mg of prasugrel in both groups. The coprimary end points were major bleeding (Bleeding Academic Research Consortium 3 or 5) for superiority and cardiovascular events (a composite of cardiovascular death, myocardial infarction, definite stent thrombosis, or ischemic stroke) for noninferiority with a relative 50% margin. RESULTS: The full analysis set population consisted of 5966 patients (no-aspirin group, 2984 patients; DAPT group, 2982 patients; age, 71.6±11.7 years; men, 76.6%; acute coronary syndrome, 75.0%). Within 7 days before randomization, aspirin alone, aspirin with P2Y12 inhibitor, oral anticoagulants, and intravenous heparin infusion were given in 21.3%, 6.4%, 8.9%, and 24.5%, respectively. Adherence to the protocol-specified antiplatelet therapy was 88% in both groups at 1 month. At 1 month, the no-aspirin group was not superior to the DAPT group for the coprimary bleeding end point (4.47% and 4.71%; hazard ratio, 0.95 [95% CI, 0.75–1.20]; P superiority =0.66). The no-aspirin group was noninferior to the DAPT group for the coprimary cardiovascular end point (4.12% and 3.69%; hazard ratio, 1.12 [95% CI, 0.87–1.45]; P non inferiority =0.01). There was no difference in net adverse clinical outcomes and each component of coprimary cardiovascular end point. There was an excess of any unplanned coronary revascularization (1.05% and 0.57%; hazard ratio, 1.83 [95%CI, 1.01–3.30]) and subacute definite or probable stent thrombosis (0.58% and 0.17%; hazard ratio, 3.40 [95% CI, 1.26–9.23]) in the no-aspirin group compared with the DAPT group. CONCLUSIONS: The aspirin-free strategy using low-dose prasugrel compared with the DAPT strategy failed to attest superiority for major bleeding within 1 month after PCI but was noninferior for cardiovascular events within 1 month after PCI. However, the aspirin-free strategy was associated with a signal suggesting an excess of coronary events. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04609111.

20 August 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
KOKozo Okada
Kozo Okada
KHKiyoshi Hibi
Kiyoshi Hibi
MGMasaomi Gohbara
Masaomi Gohbara
SKShunsuke Kataoka
Shunsuke Kataoka
KTKeiko Takano
Keiko Takano
KKKazuo Kimura
Kazuo Kimura
Blood glucose variability is receiving considerable attention as a new risk factor for coronary artery disease. This study aimed to investigate the association between blood glucose variability and coronary plaque tissue characteristics. In 57 patients with acute coronary syndrome, integrated backscatter intravascular ultrasound (IB-IVUS) and gray-scale IVUS were performed before balloon dilatation or stent implantation in the culprit vessels. Standard IVUS indices were evaluated for volume index (volume/length), and plaque components were measured by IB-IVUS for percent tissue volume. In addition to conventional glucose indicators, blood glucose variability in a stable state was determined by calculating the mean amplitude of glycemic excursions (MAGE) using a continuous glucose monitoring system. Higher MAGE values were significantly correlated with larger percent plaque volumes (r = 0.32, p = 0.015), and increased lipid (r = 0.44, p = 0.0006) and decreased fibrous (r = −0.45, p = 0.0005) plaque components. In contrast, HbA1c or fasting plasma glucose values were not significantly correlated with plaque volumes and percent plaque components. Homeostasis model assessment of insulin resistance values were positively correlated with vessel (r = 0.35, p = 0.007) and plaque (r = 0.27, p = 0.046) volumes, but not with percent plaque components. In multiple regression analysis, higher MAGE values were independently associated with increased lipid (β = 0.80, p = 0.0035) and decreased fibrous (β = -0.79, p = 0.0034) contents in coronary plaques. Among all glucose indicators studied, only higher blood glucose variability was an independent determinant of increased lipid and decreased fibrous contents with larger plaque burden, suggesting blood glucose variability as one of the important factors related to coronary plaque vulnerability.

1 August 2018 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
KHKiyoshi Hibi
Kiyoshi Hibi
KKKen Kozuma
Ken Kozuma
SSShinjo Sonoda
Shinjo Sonoda
TETsutomu Endo
Tsutomu Endo
HTHiroyuki Tanaka
Hiroyuki Tanaka
TITakaaki Isshiki
Takaaki Isshiki

1 January 2018 in Circulation Journal
Verified
Journal Article
Open access
PDF file
KHKiyoshi Hibi
Kiyoshi Hibi
SSShinjo Sonoda
Shinjo Sonoda
MKMasanori Kawasaki
Masanori Kawasaki
YOYutaka Otsuji
Yutaka Otsuji
TMToyoaki Murohara
Toyoaki Murohara
FIfor the Ezetimibe-ACS Investigators
for the Ezetimibe-ACS Investigators
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

17 October 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
SKSeita Kondo
Seita Kondo
TMTakuya Mizukami
Takuya Mizukami
NKNobuaki Kobayashi
Nobuaki Kobayashi
KWKohei Wakabayashi
Kohei Wakabayashi
HMHiroyoshi Mori
Hiroyoshi Mori
TITACTICS investigators
TACTICS investigators
Background: The prognostic impact of optical coherence tomography–diagnosed culprit lesion morphology in acute coronary syndrome (ACS) has not been systematically examined in real‐world settings. Methods and Results: This investigator‐initiated, prospective, multicenter, observational study was conducted at 22 Japanese hospitals to identify the prevalence of underlying ACS causes (plaque rupture [PR], plaque erosion [PE], and calcified nodules [CN]) and their impact on clinical outcomes. Patients with ACS diagnosed within 24 hours of symptom onset undergoing emergency percutaneous coronary intervention were enrolled. Optical coherence tomography–guided percutaneous coronary intervention recipients were assessed for underlying ACS causes and followed up for major adverse cardiac events (cardiovascular death, myocardial infarction, heart failure, or ischemia‐driven revascularization) at 1 year. Of 1702 patients with ACS, 702 (40.7%) underwent optical coherence tomography–guided percutaneous coronary intervention for analysis. PR, PE, and CN prevalence was 59.1%, 25.6%, and 4.0%, respectively. One‐year major adverse cardiac events occurred most frequently in patients with CN (32.1%), followed by PR (12.4%) and PE (6.2%) (log‐rank P <0.0001), primarily driven by increased cardiovascular death (CN, 25.0%; PR, 0.7%; PE, 1.1%; log‐rank P <0.0001) and heart failure trend (CN, 7.1%; PR, 6.8%; PE, 2.2%; log‐rank P <0.075). On multivariate Cox regression analysis, the underlying ACS cause was associated with 1‐year major adverse cardiac events (CN [hazard ratio (HR), 4.49 [95% CI, 1.35–14.89], P =0.014]; PR (HR, 2.18 [95% CI, 1.05–4.53], P =0.036]; PE as reference). Conclusions: Despite being the least common, CN was a clinically significant underlying ACS cause, associated with the highest future major adverse cardiac events risk, followed by PR and PE. Future studies should evaluate the possibility of ACS underlying cause‐based optical coherence tomography–guided optimization.

1 January 2015 in Circulation Journal
Verified
Journal Article
Closed access
SKShunsuke Kataoka
Shunsuke Kataoka
MGMasaomi Gohbara
Masaomi Gohbara
NINoriaki Iwahashi
Noriaki Iwahashi
KSKentaro Sakamaki
Kentaro Sakamaki
TNTatsuya Nakachi
Tatsuya Nakachi
KKKazuo Kimura
Kazuo Kimura
MAGE early after the onset of ACS is a predictor of RP of non-culprit lesions.